Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
Hematologic Oncology Update
00:00
Relapsed/Refractory DLBCL: Glofitamab, ADCs, and Non‑CAR Options
Sonali covers STAR‑GLOW, politzumab‑vodotin, tofelnetin, and loncastuximab data as alternative post‑frontline strategies.
Play episode from 37:51
Transcript
